Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: UK Shares Dragged Down By Commodity Weakness

Wed, 01st Jun 2016 16:07

LONDON (Alliance News) - UK stocks closed lower on Wednesday, starting June in the red, as commodity stocks fell and a weak trading update hit shares in building materials company Wolseley.

The FTSE 100 closed down 0.6%, or 38.86 points, to 6,191.93, and the FTSE 250 closed down 0.7%, or 123.26 points, at 17,061.47. The AIM All-Share closed down 0.3%, or 2.34 points, to 737.16. In mainland Europe, the CAC 40 in Paris closed down 0.7%, and the DAX in Frankfurt fell 0.6%.

Commodity stocks dragged on London's blue-chip index, with Antofagasta, down 4.0%, Rio Tinto, down 3.7%, and Glencore, down 1.7%, all among the biggest fallers, on lower iron ore prices and lacklustre Chinese manufacturing data.

"It's been an unhappy to start to June for equity markets with big slides across the board led by basic resource stocks and weakness in commodity prices, as concerns about the global economy reassert themselves once more," Michael Hewson, chief market analyst at CMC Markets UK, said.

The results of a survey by Markit and Caixin showed that manufacturing activity in China remained below a key threshold in May.

The manufacturing purchasing managers index fell to 49.2 in May from 49.4 the prior month, which was below the 49.3 expected by economists. A reading below 50 indicates a contraction.

"A slide below USD50 a ton in iron ore prices has helped pull mining stocks down heavily along with weak Chinese PMI data overnight," said CMC's Hewson.

The worries sparked by the weak Chinese data were partly offset by better-than-expected US manufacturing data.

The Institute for Supply Management said its purchasing managers index rose to 51.3 in May from 50.8 in April, with a reading above 50 indicating growth in the manufacturing sector. Economists had expected a reading of 50.6.

Analysts at Capital Economics said the increase in the ISM manufacturing index still leaves it at a level that has historically has been consistent with GDP growth of only 2%. But Capital Economics had feared that the ISM would drop back below the 50 mark. Coupled with the services side of the US economy "doing much better", Capital Economics said actual second-quarter GDP growth will be nearer 3%.

In the US at the London equities close, the Dow Jones Industrial Average was down 0.2%, the S&P 500 down 0.1%, and the Nasdaq Composite down 0.1%.

Also on Wednesday, the Organisation for Economic Co-operation & Development warned that a vote for the UK to leave the EU in a referendum scheduled for June 23 would have a "substantial" impact on the UK economy.

Fears that the UK could back Brexit have already "undermined" growth, according to the OECD, which said a vote to leave would hit growth across Europe and rest of the world and trigger turbulence in financial markets.

The pound fell after an ICM poll conducted on behalf of the Guardian newspaper, released before the London market close on Tuesday, showed voters split 52% to 48% in favour of Brexit.

The pound was trading at USD1.4404 at the London close, down from USD1.4553 at the close on Tuesday. The euro was trading at USD1.1172, up from USD1.1131 at Tuesday's close. Gold was trading at USD1,210.03, down from USD1,213.55 at the close on Tuesday.

Brent crude was trading at USD49.62 at the London close, down from USD50.60 at Tuesday's close, as traders await a meeting of OPEC officials in Vienna on Thursday.

Also in the FTSE 100, pharmaceutical companies were among the strongest climbers, with Shire up 2.2%, and GlaxoSmithKline up 0.2%. Mediclinic International, the private hospital group added 2.0%.

Unilever, the Anglo-Dutch consumer goods company, rose by 0.9%, after signing an agreement to sell its AdeS soy beverage business in Latin America for USD575 million. Coca-Cola Co and bottler Coca-Cola Femsa are buying the AdeS soy business.

"This sale is a step in reshaping our portfolio in Latin America to deliver sustainable growth for Unilever and enables us to sharpen our focus," Miguel Kozuszok, EVP Latin America Unilever, said.

The AdeS brand has a presence in Brazil, Mexico, Argentina, Uruguay, Paraguay, Bolivia, Chile, and Colombia.

Elsewhere, Tesco, up 1.1%, was also among the risers, after it posted the slowest sales decline out of the big four supermarkets in the 12 weeks ended May 22.

According to sales data published by Kantar Worldpanel, UK supermarket sales rose by 0.1% year-on-year, the same rate as in the preceding 12-week period. Kantar said this was a positive performance for the overall market, as food price deflation remains at 1.5%.

Tesco's sales fell by 1.0% in the period and its market share slipped to 28.3% from 28.6%. That was a sign of stability in comparison to the "historic declines" that the UK's biggest retailer has faced over the past two years, Kantar Director Edward Garner said.

J Sainsbury, down 4.3%, which until last month had been posting consistent periods of sales growth, saw its sales fall by 1.2% and its market share slip to 16.2% from 16.5%.

Garner said this was due to a decline in multi-pack sales, as the supermarket shifts its promotional emphasis from multi-pack deals to straightforward price cuts.

Sainsbury's was joined by Wolseley, a distributor of heating and plumbing products and a supplier of builders' products, in the list of heaviest fallers in the blue-chip index.

Wolseley slumped by 5.7% after the company said revenue growth has slowed since the end of April, following a third quarter performance dulled by weak European businesses.

In the weeks since the third quarter ended on April 30, Wolseley said, like-for-like revenue growth has been 1.0%, compared to 2.8% in the prior quarter.

The company pledged to further restructuring in the UK and Europe, meaning the total costs of doing so in the financial year ending in July will rise to GBP20.0 million from the GBP15.0 million previously expected.

The news comes less than a week after Wolseley abandoned plans to hire defence and aerospace group Cobham's chief financial officer, Simon Nicholls.

That decision was seen by Barclays, Wolseley's broker, as a move to avoid "possible reputational risk" after Cobham in April warned that trading profit in the first quarter was GBP15.0 million, well behind the GBP50.0 million made in the first quarter of 2015.

Following the market close Wednesday FTSE Russell confirmed the changes to come about thanks to the quarterly review of the FTSE indices. Pharmaceutical company Hikma Pharmaceuticals will move back to the FTSE 100, while satellite communications firm Inmarsat will be demoted to the FTSE 250.

On the economic front on Thursday, expect monetary base and foreign investment data for stocks and bonds in Japan at 0050 BST. UK PMI construction data are due at 0930 BST, followed by EU producer price index data at 1000 BST.

The European Central Bank is set to take centre stage at 1245 BST. The ECB is expected to remain in "wait and see mode" at its June meeting on Thursday as the Governing Council continues to assess the myriad policy interventions made in March. The ECB's policy decision will be followed by a press conference with ECB President Mario Draghi at 1330 BST.

Draghi is one of several central bankers set to capture the attention of markets on Thursday, with FOMC Member Powell speaking at 1335 BST and Bank of England Governor Mark Carney at 1400 BST.

In the US, ADP Employment Change data comes at 1315 BST, followed by jobless claims data at 1330 BST. EIA natural gas storage and crude oil stocks data come at 1530 BST and 1600 BST.

In the corporate calendar, Johnson Matthey publishes annual results on Thursday, with analysts widely viewing the 2016 financial year as an "off" period for the company, after which robust growth will resume thanks to increasingly stringent emissions regulations on motor vehicles.

The FTSE 100-listed platinum and chemicals company, which makes emission control systems, catalysts and fine chemicals, affirmed guidance for the financial year that ended in March in its third-quarter trading update in February.

But Johnson Matthey said macroeconomic factors, particularly the low oil price, the slowdown of economic growth in China and lower platinum prices, had continued to prove a challenge and were likely to remain an issue in the final quarter.

RPC Group also published full-year earnings.

By Samuel Agini; samagini@alliancenews.com; @SamuelAgini

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.